PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsVirus diseases
MeSH D014777 - virus diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007239:Infections
$
Success rate
D014777: 
Virus diseases
D000086965:Viral zoonoses
0 Companies
0 Drugs
Success rate
D001102:Arbovirus infections
0 Companies
0 Drugs
Success rate
D001990:Viral bronchiolitis
0 Companies
0 Drugs
Success rate
D004266:Dna virus infections
0 Companies
0 Drugs
Success rate
D006524:Viral hepatitis animal
0 Companies
0 Drugs
Success rate
D006525:Viral hepatitis human
0 Companies
0 Drugs
Success rate
D011024:Viral pneumonia
0 Companies
0 Drugs
Success rate
D012327:Rna virus infections
0 Companies
0 Drugs
Success rate
D012897:Slow virus diseases
0 Companies
0 Drugs
Success rate
D014412:Tumor virus infections
0 Companies
0 Drugs
Success rate
D014766:Viremia
0 Companies
0 Drugs
Success rate
D015229:Viral sexually transmitted diseases
0 Companies
0 Drugs
Success rate
D015828:Viral eye infections
0 Companies
0 Drugs
Success rate
D017193:Viral skin diseases
0 Companies
0 Drugs
Success rate
D020805:Central nervous system viral diseases
0 Companies
0 Drugs
Success rate
D055761:Avian reticuloendotheliosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaRibavirin Ribavirin  2004-10-04   
Ribavirin Ribavirin Teva  2009-03-31   
Ribavirin Ribavirin Teva Pharma B.V  2009-07-01   
MylanRibavirin Ribavirin Mylan (previously Ribavirin Three Rivers)  2010-06-10   
RocheRibavirin Copegus  2002-12-03   
Ribavirin, Peginterferon alfa-2a Pegasys Copegus  2004-06-04   
SandozRibavirin Ribavirin  2006-10-03   
Bausch Health CompaniesRibavirin Virazole  1985-12-31   
Merck & CoRibavirin Cotronak  1999-05-07   
Ribavirin, Peginterferon alfa-2b PegIntron/ Rebetol Combo Pack  2008-06-13   
Ribavirin Rebetol  1998-06-03   
Aurobindo PharmaRibavirin Ribavirin  2009-09-17   
Zydus TherapeuticsRibavirin Ribavirin  2005-12-05   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
71%
5/7
Phase 2
27%
7/26
Phase 3
31%
5/16
Approved: 5Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
GSK
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use